Science & Enterprise subscription

Follow us on Twitter

  • In one of its first actions, the Biden administration rejoined the United States in the World Health Organization,… https://t.co/gpHTTr70DP
    about 13 hours ago
  • New post on Science and Enterprise: U.S. Rejoins WHO, Participates in Int’l Vaccine Project https://t.co/bBUZr5UzSg #Science #Business
    about 13 hours ago
  • A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower ris… https://t.co/EPYrP8wElE
    about 17 hours ago
  • New post on Science and Enterprise: Antibodies Prevent Covid-19 Symptoms in Long-Term Care https://t.co/sePqojZMVd #Science #Business
    about 17 hours ago
  • Another way to connect 100 million people end-to-end with Covid-19 vaccines. https://t.co/wIWk0XNDhv
    about 1 day ago

Please share Science & Enterprise

Gates Funding Home-Based Crispr Covid-19 Diagnostic

Crispr graphic

A medical device developer is receiving a Gates Foundation grant for a simple test to detect Covid-19 infections, done completely at home. . . . → Read More: Gates Funding Home-Based Crispr Covid-19 Diagnostic

AbbVie Acquires Coronavirus Antibody Therapy

SARS-Cov-2 virus

Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June. . . . → Read More: AbbVie Acquires Coronavirus Antibody Therapy

Bayer Gains Lung Cancer Therapy in $670M Deal

Lung cancer illustration

Global drug maker Bayer AG is licensing an engineered T-cell therapy to treat mesothelioma and other solid tumor cancers from biotech Atara Biotherapeutics. . . . → Read More: Bayer Gains Lung Cancer Therapy in $670M Deal

Small Biz Grant Funds AI Repro Health Technology

Glasses, computer screens

A company developing health metrics with artificial intelligence received a grant to better understand polycystic ovary syndrome, an endocrine disorder affecting women. . . . → Read More: Small Biz Grant Funds AI Repro Health Technology

Inexpensive Chip Detects Covid-19, Other Pathogens

TriSilix chip

A small silicon lab-on-a-chip device costing about $0.35 to make is shown in lab tests to quickly detect SARS-CoV-2 viruses and infectious bacteria. . . . → Read More: Inexpensive Chip Detects Covid-19, Other Pathogens

Simpler Method Devised to Validate Covid-19 Tests

Covid-19 testing

An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2 viruses responsible for Covid-19. . . . → Read More: Simpler Method Devised to Validate Covid-19 Tests

Biotech Creating More Efficient Crispr Therapies

DNA puzzle

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies

Wheat Genome Study IDs Critical Genes, Traits

Curtis Pozniak in wheat field

An international research team identified key features of the complex wheat genome, including genes affecting the grain’s yield, quality, and survival. . . . → Read More: Wheat Genome Study IDs Critical Genes, Traits

Biotech Manufacturing, Distribution Company Underway

Vaccine vials

A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations. . . . → Read More: Biotech Manufacturing, Distribution Company Underway

Nanoscale Particles Deliver Crispr Cancer Treatments

Crispr-Cas9 illustration

Researchers in Israel developed techniques to deliver gene editing therapies with lipid nanoscale particles that in lab mice killed cancer cells and increased survival. . . . → Read More: Nanoscale Particles Deliver Crispr Cancer Treatments